MRC1 and Lynch syndrome: For the reference group of dMMR Lynch syndrome tumors, 13 of the 16 (81.3%) harbored a detectable somatic second hit in the same MMR gene harboring the germline pathogenic variant, which included single somatic mutations (6/13, 46%) and LOH (7/13, 53.8%) (Table S1, Figure S3A).